Infinity Pharmaceuticals Inc (NASDAQ:INFI)

1.86
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
0.93
Today|||52-Week Range
3.84
-8.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.00165.0M109.1M18.7M
 
 
 
 
Depreciation And Amortization1.8M1.8M2.3M3.4M
 
 
 
 
 
 
Operating ExpensesGross Income-1.8M------
 
 
General Expenses125.9M171.1M233.9M139.9M
 
 
 
 
 
Research And Development97.9M143.6M199.1M106.9M
 
 
 
 
 
Total Operating Expenses127.7M172.9M236.2M143.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-127.7M-7.9M-127.1M-124.6M
 
 
 
 
 
Extraordinary Credit0.000.000.00114.9M
 
 
Extraordinary Charge0.000.000.00-21.2M
 
 
Interest Expense On Debt0.009.6M1.4M1.2M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-126.8M-17.2M-128.0M-30.1M
 
 
 
 
 
Income Taxes0.00-183.0K-335.0K0.00
 
 
 
Net Income-126.8M-17.4M-128.4M-30.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS47.9M48.6M49.1M49.6M
 
 
 
 
 
Shares To Calculate EPS Diluted47.9M48.6M49.1M49.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.64-$0.36-$2.62-$0.61
 
 
 
 
 
EPS Diluted-$2.64-$0.36-$2.62-$0.61